Patent · US Expired

Certain aryl substituted pyrrolopyrazines; a new class of GABA brain receptor ligands

US5286860A · kind A · utility

9Cited by
5References
21Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 12, 1992
Grant dateFeb 15, 1994
Priority date
Expiry dateNov 12, 2012

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D487/04
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

This invention encompasses compounds of the formula: ##STR1## and pharmaceutically acceptable non-toxic salts thereof wherein: ##STR2## represents: ##STR3## where n is 0, 1, or 2; R.sub.1 and R.sub.2 are hydrogen or straight or branched chain alkyl groups; PA0 Y represents various organic and inorganic substituents; PA0 W represents an aromatic group substituted with various organic and inorganic substituents; PA0 A is CH or N; PA0 B is a substituted or unsubstituted carbon or N; and PA0 E is hydrogen or straight or branched alkyl groups These compounds are highly selective agonists, antagonists or inverse agonists for GABAa brain receptors or prodrugs thereof and are useful in the diagnosis and treatment of anxiety, sleep, and seizure disorders, overdose with benzodiazepine type drugs, and enhancement of alertness.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.